000026372 000__ 01848cam\a22004335i\4500
000026372 001__ 26372
000026372 003__ SzGeWIPO
000026372 005__ 20210318105035.0
000026372 008__ 110223s2004    fr |||||r|||| 00| 0 eng d
000026372 035__ $$a(wipo)0
000026372 035__ $$a(OCoLC)1160926021
000026372 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000026372 043__ $$aa-ii---
000026372 08204 $$a338.954$$222
000026372 084__ $$aF 68 GUE.A
000026372 090__ $$c28763$$d28753
000026372 1001_ $$aGuennif, Samira.,$$eauthor.
000026372 24510 $$aAids in India :$$bpublic health related aspects of industrial and intellectual property rights policies in a developing country.
000026372 264_1 $$aParis :$$bCentre des Sciences Humaines,$$c2004.
000026372 300__ $$a172 pages ;$$c22 cm.
000026372 336__ $$atext$$btxt$$2rdacontent
000026372 337__ $$aunmediated$$bn$$2rdamedia
000026372 338__ $$avolume$$bnc$$2rdacarrier
000026372 4901_ $$aCsh Occasional Paper,$$x0972-3579 ;$$vNo. 8
000026372 5050_ $$a1. Introduction; 2. Status of the epidemic: India's specificities; 3. Aids - a public health problem; 4. Main public health measures; 5. The Indian pharmaceutical industry - from a "Strong" IPR system to a "Weak" IPR system; 6. Arv production in India: the main players cipla and ranbaxy; 7. Access of Indian patients to arv treatments today and tomorrow; 8. Conclusion.
000026372 650_0 $$aPublic health$$zIndia.
000026372 650_0 $$aIntellectual property.
000026372 650_0 $$aIntellectual property$$zIndia.
000026372 650_4 $$aPublic health
000026372 650_4 $$aPharmaceutical industry
000026372 651_0 $$aIndia$$xCommerce$$xLaw and legislation.
000026372 7102_ $$aFrance.$$bAmbassade (INDIA)
000026372 7102_ $$aInstitut Français De Pondichéry.
000026372 7102_ $$aCentre De Sciences Humaines (New Delhi)
000026372 830_0 $$aCsh Occasional Paper ;$$vNo. 8.
000026372 903__ $$aCSH occasional paper no. 8
000026372 942__ $$cMON$$jF 68 GUE.A
000026372 952__ $$w2011-02-23$$p2011-0157$$u40631$$bMAIN$$10$$kF 68 GUE.A$$v2011-02-23$$zTagged$$71$$cLibrary
000026372 980__ $$aBIB
000026372 999__ $$c28763$$d28763